These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3568864

  • 1. [Nephrotic syndrome and hypercoagulable state].
    Zhou XJ, Zhuo HY, Liu YQ.
    Zhonghua Nei Ke Za Zhi; 1986 Dec; 25(12):729-31, 776. PubMed ID: 3568864
    [No Abstract] [Full Text] [Related]

  • 2. [Primary nephrotic syndrome treated with urokinase--a report of 20 cases].
    Wang LS, Chen EH, Zhou XJ.
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):356-9, 382. PubMed ID: 2582915
    [Abstract] [Full Text] [Related]

  • 3. [A study on the urokinase treatment in patients with glomerulonephritis and nephrotic syndrome].
    Konishi K, Kato E, Iyori S, Higashi F.
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):429-44. PubMed ID: 6750187
    [No Abstract] [Full Text] [Related]

  • 4. [Fibrinolytic system in patients with nephrotic syndrome].
    Andreenko GV, Poliantseva LR, Smirnova TA, Podorol'skaia LV.
    Ter Arkh; 1976 Apr; 40(2):89-99. PubMed ID: 135367
    [No Abstract] [Full Text] [Related]

  • 5. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
    Takasaki H, Shibata M.
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of urokinase therapy in patients with glomerulonephritis and nephrotic syndrome. Trial at multiple institutes in Japan].
    Tomura S, Takeuchi J, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1984 Jan; 26(1):97-121. PubMed ID: 6376892
    [No Abstract] [Full Text] [Related]

  • 7. [Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)].
    Shibata M, Shimizu K, Kishi T, Kobayashi K, Sakai H, Sugiyama H, Oguri M.
    Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1197-207. PubMed ID: 6450847
    [No Abstract] [Full Text] [Related]

  • 8. Plasminogen activator in nephrotic syndrome.
    Andreenko GV, Podoroldskaya LV, Polyantseva LP.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Sep; 115(3):351-5. PubMed ID: 2465229
    [Abstract] [Full Text] [Related]

  • 9. [Adrenal cortex function in nephrotic syndrome].
    Kinoshita Y, Hoshino T.
    Saishin Igaku; 1967 Feb; 22(2):315-26. PubMed ID: 4294296
    [No Abstract] [Full Text] [Related]

  • 10. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH.
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [Abstract] [Full Text] [Related]

  • 11. [A study of urokinase lysis time in patients with various renal diseases].
    Shimizu K, Kishi T, Ootaka M, Yamamoto J, Shibata M, Ban I, Sakai H, Kobayashi K.
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1233-41. PubMed ID: 6762457
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between histologic findings and effects of glucocorticoid therapy on the nephrotic syndrome.
    Kinoshita Y, Kosokabe K, Yokoyama Y, Morita T.
    Acta Med Biol (Niigata); 1965 Jun; 13(1):79-94. PubMed ID: 5852290
    [No Abstract] [Full Text] [Related]

  • 13. High dose urokinase against massive pulmonary embolism in nephrotic syndrome.
    Chen G, Liu Y, Xie Y, Li J, Liu H, Sun L, Peng Y, Liu F.
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):439-43. PubMed ID: 23386277
    [Abstract] [Full Text] [Related]

  • 14. [Fatty acid analysis by gas-liquid chromatography in the field of pediatrics. 2. Fatty acid composition in kidney diseases in children with special reference to nephrotic syndrome and its variation due to adrenocortical hormone therapy].
    Sekiya S.
    Nihon Shonika Gakkai Zasshi; 1969 Nov; 73(11):1783-8. PubMed ID: 5393372
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of the nephrotic syndrome in out-patients.
    Pochanugool C, Suvanpha R, Sitprija V.
    J Med Assoc Thai; 1979 Jul; 62(7):345-9. PubMed ID: 479719
    [No Abstract] [Full Text] [Related]

  • 16. [Cholesterol level and content of calcium and magnesium in plasma in nephrotic syndrome in children].
    Halikowski B, Kucharska K, Sancewicz-Pach K.
    Pediatr Pol; 1969 May; 44(5):561-6. PubMed ID: 5791320
    [No Abstract] [Full Text] [Related]

  • 17. [C D-S mixture (Chinese herbal drugs) in the treatment of hyper-hemoviscosity state in nephrotic syndrome and analysis of its therapeutic effects].
    Zhu PJ.
    Zhong Xi Yi Jie He Za Zhi; 1988 Apr; 8(4):207-9, 195. PubMed ID: 3191541
    [No Abstract] [Full Text] [Related]

  • 18. [Results of corticotherapy in the primary nephrotic syndromes in adults].
    Fries D, Brunat N, François B, Traeger J.
    J Urol Nephrol (Paris); 1965 Sep; 71(9):714-27. PubMed ID: 5859056
    [No Abstract] [Full Text] [Related]

  • 19. [A study of fibrinolytic therapy in glomerulonephritis and nephrotic syndrome. III. Indication, time to start therapy and criteria of effect (author's transl)].
    Sato M, Nakazora H, Ohfuji T.
    Nihon Jinzo Gakkai Shi; 1977 Sep; 19(9):717-31. PubMed ID: 599731
    [No Abstract] [Full Text] [Related]

  • 20. [Antimitotic drugs in the treatment of the nephrotic syndrome].
    Perlińska-Schnejder L, Gutka A.
    Pol Tyg Lek; 1968 Sep 19; 23(34):1276-7. PubMed ID: 5722526
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.